Jane Street
NVCT icon

Jane Street’s Nuvectis Pharma NVCT Stock Holding History

Jane Street’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
+26,400
New +$296K ﹤0.01% 8090

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Jane Street's NVCT Position: Q2 2026 in Review

Jane Street opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 15,582 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #9310 among its holdings. This is a return to the name: Jane Street previously reported a position in NVCT as recently as Q3 2025.

Jane Street first reported a position in NVCT in Q1 2023 and has held it in 5 quarters since. The position peaked at $413K in Q1 2025. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Jane Street held 15,582 shares of Nuvectis Pharma worth $287K as of Q2 2026.
  • Nuvectis Pharma was a new Jane Street position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9310 holding.
  • Jane Street first reported a position in Nuvectis Pharma in Q1 2023 and has held it in 5 quarters since.
  • Jane Street's Nuvectis Pharma position peaked at $413K in Q1 2025.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.